Immune Checkpoint inhibitors
Immune checkpoint inhibitors, commonly known as checkpoint inhibitors are drugs which ‘take the brakes off’ the immune system, allowing tumour cells to be destroyed.
There are currently no checkpoint inhibitor treatments approved for treating brain tumours within the NHS.
There is, however, growing interest in combining checkpoint inhibitors with chemotherapy, radiotherapy, and other treatments to boost their effectiveness. Different drugs and approaches are still being tested in clinical trials across the world. For example, some checkpoint inhibitors currently in research include:
- Ipilimumab
- Pembrolizumab
- Nivolumab
- Pidilizumab
You can learn more about finding clinical trials here.
How checkpoint inhibitors work
Taking the brakes off the immune system
Make the right choices for you
How checkpoint inhibitors work
Normal cells in your body have particular proteins on their surface that the immune system recognises as friendly, so your body’s immune system doesn’t attack them. As these proteins effectively hold the immune system in check, medical experts call them ‘checkpoint proteins’.
However, tumour cells can sometimes fool the immune system by also producing these checkpoint proteins, preventing the immune system from recognising them as unfriendly and from attacking them.
‘Checkpoint inhibitors’ are drugs that block these checkpoint proteins, so the tumour cells now become visible to the immune system and the ‘brakes’ are taken off the immune system, allowing the tumour cells to be destroyed.
The down-side of this, however, is that it also takes the brakes off the immune system attacking your normal cells. This can lead to various side-effects, which can occur at any time and can affect many different organs.
Taking the brakes off the immune system
Narrated by Jill O’Donnell-Tormey, Ph.D. from the Cancer Research Institute, this 1-minute animated video provides a quick overview of checkpoint inhibitors.
Side effects
The most common side-effects are a rash, diarrhoea, reduced levels of thyroid hormone, and fatigue. More severe side-effects can be due to inflammation of the lung, intestines or liver, hormonal abnormalities, and kidney, heart, or neurologic problems.
If the side-effects are mild, it may be possible to continue using the checkpoint inhibitors, but you will have close monitoring.
Some people may have to take corticosteroids to reduce the inflammation. Your medical team will then modify your treatment plan depending on what is best for you.
Make the right choices for you
Our Step by Step interactive guide outlines what happens following a diagnosis, to answer your questions and help you to understand what to expect.
Checkpoint inhibitors are used by medical teams to treat some types of cancer such as skin and lung cancer. However, there is currently not sufficient evidence to show that checkpoint inhibitors are effective against brain tumours. There are a number of clinical trials and research ongoing all around the world to find better and more effective treatments against brain tumours.
Support and Information Services
Research & Clinical Trials Information
You can also join our active online community.
In this section
Share your experiences and help create change
By taking part in our Improving Brain Tumour Care surveys and sharing your experiences, you can help us improve treatment and care for everyone affected by a brain tumour.